Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

N4 Pharma Plc (N4P) Share Price

Price 0.525p on 16-12-2025 at 08:02:06
Change 0.00p 0%
Buy 0.55p
Sell 0.50p
Last Trade: Buy 279,850.00 at 0.536p
Day's Volume: 0
Last Close: 0.525p
Open: 0.525p
ISIN: GB00BYW8QM32
Day's Range 0.525p - 0.525p
52wk Range: 0.35p - 0.80p
Market Capitalisation: £4.37m
VWAP: 0.00p
Shares in Issue: 832.28m

N4 Pharma Plc (N4P) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 279,850 0.536p Ordinary
12:54:10 - 15-Dec-25
Sell* 2,332 0.505p Ordinary
08:41:09 - 15-Dec-25
Sell* 75,000 0.5055p Ordinary
08:33:55 - 15-Dec-25
Sell* 206,900 0.506p Ordinary
14:38:49 - 12-Dec-25
Sell* 5,326 0.5055p Ordinary
14:01:09 - 12-Dec-25
Sell* 12,107 0.5055p Ordinary
10:01:44 - 12-Dec-25
Buy* 689,013 0.537p Ordinary
08:12:05 - 12-Dec-25
Sell* 200 0.505p Ordinary
10:35:45 - 11-Dec-25
Sell* 1,000 0.505p Ordinary
15:16:54 - 10-Dec-25
Sell* 700 0.505p Ordinary
11:46:39 - 09-Dec-25
See more N4 Pharma Plc trades

N4 Pharma Plc (N4P) Share Price History

Time period:
to
Date Open High Low Close Volume
16th Dec 2025 (Tue) 0.525 0.525 0.525 0.525 0
15th Dec 2025 (Mon) 0.525 0.525 0.525 0.525 357,182
12th Dec 2025 (Fri) 0.525 0.525 0.525 0.525 913,346
11th Dec 2025 (Thu) 0.525 0.525 0.525 0.525 200
10th Dec 2025 (Wed) 0.525 0.525 0.525 0.525 1,000
9th Dec 2025 (Tue) 0.525 0.525 0.525 0.525 37,655
8th Dec 2025 (Mon) 0.575 0.575 0.525 0.525 4,450,609
5th Dec 2025 (Fri) 0.575 0.575 0.575 0.575 126,217
4th Dec 2025 (Thu) 0.575 0.575 0.575 0.575 94,661
3rd Dec 2025 (Wed) 0.575 0.575 0.575 0.575 0
2nd Dec 2025 (Tue) 0.575 0.575 0.575 0.575 6,656
1st Dec 2025 (Mon) 0.575 0.575 0.575 0.575 0
28th Nov 2025 (Fri) 0.575 0.575 0.575 0.575 12,004
27th Nov 2025 (Thu) 0.575 0.575 0.575 0.575 37,084
26th Nov 2025 (Wed) 0.575 0.575 0.575 0.575 244,614
25th Nov 2025 (Tue) 0.575 0.575 0.575 0.575 506,312
24th Nov 2025 (Mon) 0.625 0.625 0.575 0.575 2,082,969
21st Nov 2025 (Fri) 0.625 0.625 0.625 0.625 263,039
20th Nov 2025 (Thu) 0.625 0.625 0.625 0.625 169,794
19th Nov 2025 (Wed) 0.625 0.625 0.625 0.625 80,242
18th Nov 2025 (Tue) 0.625 0.625 0.625 0.625 673,903
17th Nov 2025 (Mon) 0.625 0.625 0.625 0.625 26,577
See more N4 Pharma Plc price history

N4 Pharma Plc (N4P) Regulatory News

Date Source Headline
25th Sep 2025 7:00 am RNS Interim Results
23rd Sep 2025 7:00 am RNS Partnership with University of Strathclyde’s CMAC
22nd Sep 2025 7:00 am RNS N4 Pharma’s Nuvec® Targets Lung Cancer Cells
19th Sep 2025 7:00 am RNS Notice of Results, Analyst & Investor Presentation
11th Sep 2025 7:00 am RNS-R Investor Event and Presentation
30th Jul 2025 1:55 pm RNS-R Article on Nuvec®’s Potential in RNA Therapeutics
14th Jul 2025 7:00 am RNS-R Investor Webinar
8th Jul 2025 7:00 am RNS Directorate Change
30th Jun 2025 2:15 pm RNS Result of AGM
30th Jun 2025 7:00 am RNS AGM Statement
See more N4 Pharma Plc regulatory news

N4 Pharma Plc (N4P) Share News

EARNINGS AND TRADING: Comptoir loss narrows; Journeo profit down

25th Sep 2025 13:43

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: N4 Pharma teams up with University of Strathclyde facility

23rd Sep 2025 18:29

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company focused on the development of nanoparticle technology - Announces partnership with Glasgow-based University of Strathclyde's CMAC National Facility, aimed at accelerating development and broadening therapeutic applications. The collaboration combines N4 Pharma's Nuvec delivery platform with CMAc's expertise. Read More

AIM WINNERS & LOSERS: WH Ireland agrees disposal, proposes wind-down

22nd Sep 2025 11:02

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More

N4 Pharma surges as Nuvec targets RNA delivery to lung cancer cells

22nd Sep 2025 10:24

(Alliance News) - N4 Pharma PLC on Monday said its Nuvec gene delivery system has successfully demonstrated targeted delivery of RNA to lung cancer cells in collaboration with US research institute SRI. Read More

LONDON MARKET OPEN: London stocks mixed as mining stocks rise

22nd Sep 2025 09:11

(Alliance News) - London stocks were mixed at Monday's market open, with miners dominating the top spots on the FTSE 100 index while airlines were hurt after the weekend's alleged cyber attack. Read More

See more N4 Pharma Plc news
FTSE 100 Latest
Value9,732.45
Change-18.86

Login to your account

Forgot Password?

Not Registered